Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists
- Creator: Glewis, Sarah , Lingaratnam, Senthil , Krishnasamy, Michael , Martin, Jennifer H. , Tie, Jeanne , Alexander, Marliese , Michael, Michael
- Resource Type: journal article
- Date: 2024
Patient and health care professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: a cross sectional survey.
- Creator: Glewis, Sarah , Krishnasamy, Mei , Campbell, Ian , Martin, Jennifer H. , Tie, Jeanne , Alexander, Marliese , Michael, Michael , Lingaratnam, Senthil , Harris, Sam , Underhill, Craig , Georgiou, Chloe , Warren, Mark , Campbell, Robert , IJzerman, Maarten , Fagery, Mussab
- Resource Type: journal article
- Date: 2023
A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing
- Creator: Glewis, Sarah , Alexander, Marliese , Khabib, Muhammad N. H. , Brennan, Annabelle , Lazarakis, Smaro , Martin, Jennifer , Tie, Jeane , Lingaratnam, Senthil , Michael, Michael
- Resource Type: journal article
- Date: 2022